Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne
This study has been completed.
Study NCT00713609   Information provided by Stiefel, a GSK Company
First Received: July 7, 2008   Last Updated: June 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acne Vulgaris
More general conditions related to this trial
Acneiform Eruptions
Facial Dermatoses
Sebaceous Gland Diseases
Skin Diseases
Interventions listed in this trial
Clindamycin gel + tazarotene cream
Vehicle gel+ tazarotene cream
Vehicle gel + vehicle cream
Additional drug interventions recognized in this trial
Benzoyl Peroxide
Clindamycin
Clindamycin-2-phosphate
Tazarotene
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Dermatologic Agents
Enzyme Inhibitors
Keratolytic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Synthesis Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Stiefel, a GSK Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services